« Back to the previous page

Buyer of multiple pharmaceutical companies in Spain

Company to buy

• Size: medium or large business
• Revenue: +5M EUR
• Location of the target company: Spain
• Reason for acquisition: The management of a large company decided to go for acquisitions in Spain in order to grow the company
• #CFIE PHB010

Overview of this multiple pharma companies’ buyer

The management of a large pharmaceutical company wants to expand its presence in Spain and is ready for multiple acquisitions. The company wants to grow in Europe, as they only have strong presence in North African region and the Middle East.

Profile (strategy) of this multiple pharma companies buyer

The buyer is an innovative pharmaceuticals & FMCG company, based in North Africa. The headquarter of the company is based in one of the largest cities in Africa. The history of the company has more than 40 years. During this time, the company has developed more than 500 products, shipped worldwide. The company takes pride in its high-quality production facilities, strong R&D department, and quality control lab equipment with the latest analytical Instruments.

The company is very large, currently, the number of employees reach more than 1 thousand people. The orientation of the company can be divided into four sectors:

• Health
  
• Medical
  
• Pharmaceutical
  
• FMCG
  

The company is one of the leaders in the industry oriented at manufacturing, distribution, and promotion of products in the North-African region. Apart from this, the company is currently active in 10+ countries in the Middle East region.

Activities and products of the target – pharma company in Spain

This company is looking to expand its geographical reach in Europe by the acquisition of a company, suiting its preferences. The buyer has sufficient funds, therefore the buyer is open also to multiple acquisitions if more than 1 company will match with the buyer.

The target should operate in the pharma industry and should be based in Spain, as according to the expansion strategy, Spain is the key country from where the buyer will start the expansion. The preference of the buyer (but not necessity) is if the buyer is oriented at curing diseases like hepatitis, heart diseases, diabetes.

The goal of the buyer is to acquire a fully established and running pharmaceutical company with no operational problems. The preferred turnover generated by the target should exceed 10M to be interesting to the buyer, however, preferably the buyer is interested in larger companies.

Highlights of the pharma company buyer

• The buyer is a pharmaceutical company based in MENA region, with strong regional influence
• The target company should be a pharma manufacturer, orientation is not definitely specified and will be considered individually by the management
• The buyer is looking for running businesses with no operational problems

Information on this buyer of this pharma buyer

Feel free to contact us for more information regarding this pharmaceutical buyer, or if you know possible interested or suitable parties/targets for sale. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.